Cell Cycle-dependent Regulation of FLIP Levels and Susceptibility to Fas-mediated Apoptosis
Overview
Affiliations
Activation-induced cell death of peripheral T cells results from the interaction between Fas and Fas ligand. Resting peripheral T cells are resistant to Fas-induced apoptosis and become susceptible only after their activation. We have investigated the molecular mechanism mediating the sensitization of resting peripheral T cells to Fas-mediated apoptosis following TCR stimulation. TCR activation decreases the steady state protein levels of FLIP (FLICE-like inhibitory protein), an inhibitor of the Fas signaling pathway. Reconstitution of intracellular FLIP levels by the addition of a soluble HIV transactivator protein-FLIP chimera completely restores resistance to Fas-mediated apoptosis in TCR primary T cells. Inhibition of IL-2 production by cyclosporin A, or inhibition of IL-2 signaling by rapamycin or anti-IL-2 neutralizing Abs prevents the decrease in FLIP levels and confers resistance to Fas-mediated apoptosis following T cell activation. Using cell cycle-blocking agents, we demonstrate that activated T cells arrested in G1 phase contain high levels of FLIP protein, whereas activated T cells arrested in S phase have decreased FLIP protein levels. These findings link regulation of FLIP protein levels with cell cycle progression and provide an explanation for the increase in TCR-induced apoptosis observed during the S phase of the cell cycle.
Mora-Molina R, Lopez-Rivas A Int J Mol Sci. 2022; 23(16).
PMID: 36012252 PMC: 9409255. DOI: 10.3390/ijms23168987.
Kubo S, Kataria R, Yao Y, Gabrielski J, Zheng L, Markowitz T Proc Natl Acad Sci U S A. 2022; 119(33):e2208522119.
PMID: 35939714 PMC: 9388157. DOI: 10.1073/pnas.2208522119.
Mora-Molina R, Stohr D, Rehm M, Lopez-Rivas A Cell Death Dis. 2022; 13(2):111.
PMID: 35115486 PMC: 8813907. DOI: 10.1038/s41419-022-04574-6.
Woodward K, Zhao H, Shrestha P, Batra L, Tan M, Grimany-Nuno O Am J Transplant. 2019; 20(5):1285-1295.
PMID: 31850658 PMC: 7299172. DOI: 10.1111/ajt.15747.
Seo J, Lee E, Shin J, Seong D, Nam Y, Jeong M Oncogene. 2018; 37(36):4994-5006.
PMID: 29795330 DOI: 10.1038/s41388-018-0323-z.